194 related articles for article (PubMed ID: 4327336)
21. [Isolation of tubercle bacilli resistant to kanamycin or viomycine from tuberculous patients].
Endo K; Takahashi M; Hashimoto H; Mitsuhashi S
J Antibiot B; 1967 Aug; 20(4):251-3. PubMed ID: 4295238
[No Abstract] [Full Text] [Related]
22. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
Tsukamura M
Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
[No Abstract] [Full Text] [Related]
23. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
Fukuhara Y
Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
[No Abstract] [Full Text] [Related]
24. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
[TBL] [Abstract][Full Text] [Related]
25. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II].
Afanas'eva IuP; Dorozhkova IR
Lab Delo; 1969; 5():296-8. PubMed ID: 4185263
[No Abstract] [Full Text] [Related]
26. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
Tsukamura M; Mizuno S; Murata H; Oshima T
Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
[No Abstract] [Full Text] [Related]
27. The fundamental studies on antituberculous activities of lividomycin.
Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
[No Abstract] [Full Text] [Related]
28. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
Kozulitsyna TI; Kozlova NV
Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
[No Abstract] [Full Text] [Related]
29. [Isolation of kanamycin or viomycin-resistant M. tuberculosis from tuberculous patients].
Endo K; Takahashi M; Hashimoto H; Mitsuhashi S
J Antibiot B; 1967 Feb; 20(1):1-5. PubMed ID: 4292905
[No Abstract] [Full Text] [Related]
30. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
GROSSET J; CANETTI G
Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
[No Abstract] [Full Text] [Related]
31. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Makarevich NM; Rudoĭ NM
Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
[No Abstract] [Full Text] [Related]
32. Some experimental aspects of cross-resistance between capreomycin and viomycin.
Algeorge G; Petre A
Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892
[No Abstract] [Full Text] [Related]
33. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
Makarevich NM; Mkrtchian SV; Afanas'eva IuP
Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
[No Abstract] [Full Text] [Related]
34. Experimental studies on the combined effect of kanamycin and viomycin.
Hokama S
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):62-9. PubMed ID: 4320009
[No Abstract] [Full Text] [Related]
35. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
[TBL] [Abstract][Full Text] [Related]
36. [ACTIVITIES IN BLOOD OF SEVERAL ANTIMYCOBACTERIAL DRUGS DETERMINED BY THE SLIDE CELL CULTURE METHOD AS COMPARED WITH IN VITRO ACTIVITIES. I. CONCERNING STREPTOMYCIN, KANAMYCIN, CAPREOMYCIN AND VIOMYCIN].
NAGATA A; MATSUMOTO M; MASE M
Kekkaku; 1965 Jan; 40():6-11. PubMed ID: 14288531
[No Abstract] [Full Text] [Related]
37. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.
Juréen P; Angeby K; Sturegård E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schön T
J Clin Microbiol; 2010 May; 48(5):1853-8. PubMed ID: 20237102
[TBL] [Abstract][Full Text] [Related]
38. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
Tsukamura M; Toyama H
Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
[No Abstract] [Full Text] [Related]
39. The 7H11 medium for the cultivation of mycobacteria.
Cohn ML; Waggoner RF; McClatchy JK
Am Rev Respir Dis; 1968 Aug; 98(2):295-6. PubMed ID: 4299186
[No Abstract] [Full Text] [Related]
40. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
Yamada T; Mizuguchi Y; Suga K
J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
